These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21747029)

  • 1. Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis.
    Weintraub D; Chen P; Ignacio RV; Mamikonyan E; Kales HC
    Arch Neurol; 2011 Jul; 68(7):899-904. PubMed ID: 21747029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006.
    Sernyak MJ; Rosenheck RA
    Psychiatr Serv; 2008 May; 59(5):567-9. PubMed ID: 18451019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Appropriateness of Off-Label Antipsychotic Use for Mental Health Indications in a Veteran Population.
    Painter JT; Owen R; Henderson KL; Bauer MS; Mittal D; Hudson TJ
    Pharmacotherapy; 2017 Apr; 37(4):438-446. PubMed ID: 28164355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label use of antipsychotic medications in the department of Veterans Affairs health care system.
    Leslie DL; Mohamed S; Rosenheck RA
    Psychiatr Serv; 2009 Sep; 60(9):1175-81. PubMed ID: 19723731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic Use and Physical Morbidity in Parkinson Disease.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    Am J Geriatr Psychiatry; 2017 Jul; 25(7):697-705. PubMed ID: 28259697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004.
    Aparasu RR; Bhatara V
    Curr Med Res Opin; 2007 Jan; 23(1):49-56. PubMed ID: 17257465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant and antipsychotic prescribing in primary care for people with dementia.
    Drummond N; McCleary L; Freiheit E; Molnar F; Dalziel W; Cohen C; Turner D; Miyagishima R; Silvius J
    Can Fam Physician; 2018 Nov; 64(11):e488-e497. PubMed ID: 30429194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant antipsychotic prescribing in US outpatient settings.
    Aparasu RR; Jano E; Bhatara V
    Res Social Adm Pharm; 2009 Sep; 5(3):234-41. PubMed ID: 19733824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
    Bret P; Bonnet F; Bret MC; Jaffré A
    Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson disease psychosis: Update.
    Friedman JH
    Behav Neurol; 2013 Jan; 27(4):469-77. PubMed ID: 23242358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
    Morgante L; Epifanio A; Spina E; Zappia M; Di Rosa AE; Marconi R; Basile G; Di Raimondo G; La Spina P; Quattrone A
    Clin Neuropharmacol; 2004; 27(4):153-6. PubMed ID: 15319699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal outcome of Parkinson's disease patients with psychosis.
    Factor SA; Feustel PJ; Friedman JH; Comella CL; Goetz CG; Kurlan R; Parsa M; Pfeiffer R;
    Neurology; 2003 Jun; 60(11):1756-61. PubMed ID: 12796526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
    Brown JD; Cicali B; Henriksen C; Malaty I; Okun MS; Armstrong MJ
    J Manag Care Spec Pharm; 2021 Jun; 27(6):785-790. PubMed ID: 34057395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.